H.R.4404 To amend the Federal Food, Drug, and Cosmetic Act to require that the label of drugs with an increased risk of suicide or depression present such increased risk prominently, and for other purposes.
Sponsored by Bobby L. Rush (D). Introduced on 2019-09-19 in the House Energy and Commerce Committee. The last major action was Referred to the House Committee on Energy and Commerce which took place on 2019-09-19.
The full legislation document not yet available.
09/19/2019 - Referred to the House Committee on Energy and Commerce.